Zhao XJ - Search Results

1

Truncated Bid Regulates Cisplatin Response via Activation of Mitochondrial Apoptosis Pathway in Ovarian Cancer.

Dai Y, Zhao XJ, Li F, Yuan Y, Yan DM, Cao H, Huang XY, Hu Z, Ma D, Gao QL. Dai Y, et al. Among authors: zhao xj. Hum Gene Ther. 2020 Mar;31(5-6):325-338. doi: 10.1089/hum.2019.206. Epub 2020 Mar 3. Hum Gene Ther. 2020. PMID: 32024383

2

PP242 synergizes with suberoylanilide hydroxamic acid to inhibit growth of ovarian cancer cells.

Qin Y, Zhao X, Fang Y. Qin Y, et al. Int J Gynecol Cancer. 2014 Oct;24(8):1373-80. doi: 10.1097/IGC.0000000000000238. Int J Gynecol Cancer. 2014. PMID: 25188886

3

Elaiophylin, a novel autophagy inhibitor, exerts antitumor activity as a single agent in ovarian cancer cells.

Zhao X, Fang Y, Yang Y, Qin Y, Wu P, Wang T, Lai H, Meng L, Wang D, Zheng Z, Lu X, Zhang H, Gao Q, Zhou J, Ma D. Zhao X, et al. Autophagy. 2015;11(10):1849-63. doi: 10.1080/15548627.2015.1017185. Autophagy. 2015. PMID: 25893854 Free PMC article.

4

FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer.

Lai H, Zhao X, Qin Y, Ding Y, Chen R, Li G, Labrie M, Ding Z, Zhou J, Hu J, Ma D, Fang Y, Gao Q. Lai H, et al. J Exp Clin Cancer Res. 2018 Feb 20;37(1):32. doi: 10.1186/s13046-018-0696-4. J Exp Clin Cancer Res. 2018. PMID: 29458390 Free PMC article.

5

Correction to: FAK-ERK activation in cell/matrix adhesion induced by the loss of apolipoprotein E stimulates the malignant progression of ovarian cancer.

Lai H, Zhao X, Qin Y, Ding Y, Chen R, Li G, Labrie M, Ding Z, Zhou J, Hu J, Ma D, Fang Y, Gao Q. Lai H, et al. J Exp Clin Cancer Res. 2019 Oct 15;38(1):415. doi: 10.1186/s13046-019-1422-6. J Exp Clin Cancer Res. 2019. PMID: 31615580 Free PMC article.

6

Elaiophylin triggers paraptosis and preferentially kills ovarian cancer drug-resistant cells by inducing MAPK hyperactivation.

Li GN, Zhao XJ, Wang Z, Luo MS, Shi SN, Yan DM, Li HY, Liu JH, Yang Y, Tan JH, Zhang ZY, Chen RQ, Lai HL, Huang XY, Zhou JF, Ma D, Fang Y, Gao QL. Li GN, et al. Among authors: zhao xj. Signal Transduct Target Ther. 2022 Sep 12;7(1):317. doi: 10.1038/s41392-022-01131-7. Signal Transduct Target Ther. 2022. PMID: 36097006 Free PMC article.

7

Dose-dense regimen versus conventional three-weekly paclitaxel combination with carboplatin chemotherapy in first-line ovarian cancer treatment: a systematic review and meta-analysis.

Gong W, Yu R, Cao C, Fang Y, Zhao X, Gao Q. Gong W, et al. J Ovarian Res. 2023 Jul 10;16(1):136. doi: 10.1186/s13048-023-01216-z. J Ovarian Res. 2023. PMID: 37430376 Free PMC article. Review.

8

Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance.

Zhou M, Wang T, Lai H, Zhao X, Yu Q, Zhou J, Yang Y. Zhou M, et al. Biochem Biophys Res Commun. 2015 Apr 3;459(2):333-339. doi: 10.1016/j.bbrc.2015.02.115. Epub 2015 Feb 28. Biochem Biophys Res Commun. 2015. PMID: 25735983

9

Identifying therapeutic strategies for triple-negative breast cancer via phosphoproteomics.

Sheng Y, Mills G, Zhao X. Sheng Y, et al. Expert Rev Proteomics. 2024 Nov 26:1-17. doi: 10.1080/14789450.2024.2432477. Online ahead of print. Expert Rev Proteomics. 2024. PMID: 39588933 Review.

10

[Establishment of the retrovirus-mediated murine model with MLL-AF9 leukemia].

Xu SM, Yang Y, Zhou M, Zhao XJ, Qin Y, Zhang PL, Yuan RF, Zhou JF, Fang Y. Xu SM, et al. Among authors: zhao xj. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1126-32. doi: 10.7534/j.issn.1009-2137.2013.05.008. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013. PMID: 24156419 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

648 results

Search Page

Filters